Tonnaer J A, van Vugt M A, de Boer T, de Graaf J S
Life Sci. 1987 May 18;40(20):1981-7. doi: 10.1016/0024-3205(87)90287-6.
Some atypical muscarinic drugs were compared with classical drugs with respect to inhibition of specific binding of [3H]pirenzepine ([3H]PZ) and [3H]quinuclidinyl benzilate ([3H]QNB) to membrane preparations of rat brain. The interactions of the agonists McN-A343 and carbachol with [3H]QNB at muscarinic sites in brain stem preparations were differently modulated in the presence of an excess of PZ. Moreover, McN-A343 exhibited a preferential affinity for [3H]PZ sites in whole brain membranes whereas carbachol bound with high affinity to [3H]QNB sites in brain stem preparations. Various muscarinic agonists and antagonists displayed different affinity patterns in the [3H]PZ and [3H]QNB binding. These data are indicative of two populations of pharmacologically distinguishable binding sites and support the concept of muscarinic receptor heterogeneity in rat brain.
将一些非典型毒蕈碱药物与经典药物进行比较,研究它们对[3H]哌仑西平([3H]PZ)和[3H]喹核醇基苯甲酸酯([3H]QNB)与大鼠脑膜制剂特异性结合的抑制作用。在存在过量PZ的情况下,激动剂 McN-A343 和卡巴胆碱与脑干制剂中毒蕈碱位点上的[3H]QNB 的相互作用受到不同调节。此外,McN-A343 对全脑膜中的[3H]PZ 位点表现出优先亲和力,而卡巴胆碱则与脑干制剂中的[3H]QNB 位点高亲和力结合。各种毒蕈碱激动剂和拮抗剂在[3H]PZ 和[3H]QNB 结合中表现出不同的亲和力模式。这些数据表明存在两类药理学上可区分的结合位点,并支持大鼠脑中毒蕈碱受体异质性的概念。